Siglec-9 defines and restrains a natural killer subpopulation highly cytotoxic to HIV-infected cells
Open Access
- 11 November 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Pathogens
- Vol. 17 (11) , e1010034
Abstract
Siglec-9 is an MHC-independent inhibitory receptor expressed on a subset of natural killer (NK) cells. Siglec-9 restrains NK cytotoxicity by binding to sialoglycans (sialic acid-containing glycans) on target cells. Despite the importance of Siglec-9 interactions in tumor immune evasion, their role as an immune evasion mechanism during HIV infection has not been investigated. Using in vivo phenotypic analyses, we found that Siglec-9+ CD56dim NK cells, during HIV infection, exhibit an activated phenotype with higher expression of activating receptors and markers (NKp30, CD38, CD16, DNAM-1, perforin) and lower expression of the inhibitory receptor NKG2A, compared to Siglec-9- CD56dim NK cells. We also found that levels of Siglec-9+ CD56dim NK cells inversely correlate with viral load during viremic infection and CD4+ T cell-associated HIV DNA during suppressed infection. Using in vitro cytotoxicity assays, we confirmed that Siglec-9+ NK cells exhibit higher cytotoxicity towards HIV-infected cells compared to Siglec-9- NK cells. These data are consistent with the notion that Siglec-9+ NK cells are highly cytotoxic against HIV-infected cells. However, blocking Siglec-9 enhanced NK cells’ ability to lyse HIV-infected cells, consistent with the known inhibitory function of the Siglec-9 molecule. Together, these data support a model in which the Siglec-9+ CD56dim NK subpopulation is highly cytotoxic against HIV-infected cells even whilst being restrained by the inhibitory effects of Siglec-9. To harness the cytotoxic capacity of the Siglec-9+ NK subpopulation, which is dampened by Siglec-9, we developed a proof-of-concept approach to selectively disrupt Siglec/sialoglycan interactions between NK and HIV-infected cells. We achieved this goal by conjugating Sialidase to several HIV broadly neutralizing antibodies. These conjugates selectively desialylated HIV-infected cells and enhanced NK cells’ capacity to kill them. In summary, we identified a novel, glycan-based interaction that may contribute to HIV-infected cells’ ability to evade NK immunosurveillance and developed an approach to break this interaction.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01 AI165079)
- National Institute of Allergy and Infectious Diseases (R21 AI143385)
- National Institute of Allergy and Infectious Diseases (P30 AI 045008)
- National Institute of Allergy and Infectious Diseases (UM1AI164570)
- The Philadelphia Foundation (Robert I. Jacobs Fund)
- National Institute of General Medical Sciences (R35 GM133706)
- National Cancer Institute (R21 CA255894)
- U.S. Department of War (W81XWH-21-1-0789)
- Cancer Prevention and Research Institute of Texas (RR170014)
- Robert A. Welch Foundation (C-1970)
This publication has 64 references indexed in Scilit:
- Sialic acid-binding Ig-like lectin-7 interacts with HIV-1 gp120 and facilitates infection of CD4posT cells and macrophagesRetrovirology, 2013
- Post-Treatment HIV-1 Controllers with a Long-Term Virological Remission after the Interruption of Early Initiated Antiretroviral Therapy ANRS VISCONTI StudyPLOS Pathogens, 2013
- Multifarious roles of sialic acids in immunityAnnals of the New York Academy of Sciences, 2012
- Innate or Adaptive Immunity? The Example of Natural Killer CellsScience, 2011
- Identification of Siglec-9 as the receptor for MUC16 on human NK cells, B cells, and monocytesMolecular Cancer, 2010
- Functionally distinct subsets of human NK cells and monocyte/DC-like cells identified by coexpression of CD56, CD7, and CD4Blood, 2009
- The decreased expression of Siglec-7 represents an early marker of dysfunctional natural killer–cell subsets associated with high levels of HIV-1 viremiaBlood, 2009
- Siglecs and their roles in the immune systemNature Reviews Immunology, 2007
- Natural killer cells, viruses and cancerNature Reviews Immunology, 2001
- Quantification of latent tissue reservoirs and total body viral load in HIV-1 infectionNature, 1997